ChristianaCare spins off start-up company using its gene editing technology
ad_1] ChristianaCare has spun out its first industrial biotechnology start-up, CorriXR Therapeutics with $5 million in seed funding CorriXR Therapeutics (pronounced Cor-ix-er; from Galician which means to appropriate or edit)...
Read more









